Dr. Ezequiel Ramon Bellorin Font, MD

Dr. Bellorin Font practices at Fresenius Kidney Care Saint Louis Grand in Saint Louis, Missouri.

Dr. Bellorin Font's NPI, 1932619772, was assigned on October 6, 2017. Dr. Bellorin Font holds Missouri license 2019026883.

Dr. Bellorin Font's primary practice is Fresenius Kidney Care Saint Louis Grand, at 3961 Rutger St Ste 222, Saint Louis, MO 63110 in Saint Louis County. The practice phone is (314) 762-0089. Dr. Bellorin Font also practices at St. Louis Renal Care, 3691 Rutger St, Saint Louis, MO 63110.

Dr. Bellorin Font's primary practice is Fresenius Kidney Care Saint Louis Grand in Saint Louis, Missouri. Dr. Bellorin Font is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Bellorin Font to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bellorin Font practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bellorin Font's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bellorin Font is licensed in Missouri.

CMS data shows 342 Medicare services from Dr. Bellorin Font across 4 procedure codes in 2024, for 103 Medicare patients. Medicare paid $21,781 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Dr. Bellorin Font in 2024. The largest group is under 65, with 38 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 51% are also on Medicaid. Their average risk score is 7.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bellorin Font's median patient age at 66, with 46% women.

In 2024, Dr. Bellorin Font wrote 223 Medicare Part D claims for 58 patients. 86% of them were for generic drugs. CMS names the drug for 126 of them, across 7 drugs with 11 or more claims each, at $8,147 in total drug cost. In 2023, CMS named 135 claims across 6 drugs.

Dr. Bellorin Font accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Bellorin Font, published from 2019 to 2022. 2019 was the busiest year, with 3. Dr. Bellorin Font's most frequent co-author is Csaba Pal Kovesdy, MD.

CMS Open Payments shows 10 general payments to Dr. Bellorin Font from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. NxStage Medical, Inc. paid the most, $238.